A detailed history of Second Line Capital, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Second Line Capital, LLC holds 4,272 shares of JNJ stock, worth $662,330. This represents 0.19% of its overall portfolio holdings.

Number of Shares
4,272
Previous 3,138 36.14%
Holding current value
$662,330
Previous $496 Million 25.78%
% of portfolio
0.19%
Previous 0.16%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 16, 2024

BUY
$144.38 - $157.78 $163,726 - $178,922
1,134 Added 36.14%
4,272 $624 Million
Q1 2024

May 22, 2024

BUY
$155.22 - $162.74 $40,978 - $42,963
264 Added 9.19%
3,138 $496 Million
Q4 2023

Feb 09, 2024

BUY
$145.6 - $158.88 $418,454 - $456,621
2,874 New
2,874 $450 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Second Line Capital, LLC Portfolio

Follow Second Line Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Second Line Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Second Line Capital, LLC with notifications on news.